SRLV Vector System Enhancing Transduction Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Lentiviral vectors derived from small ruminant lentiviruses (SRLV) such as visna/maedi virus and caprine arthritis encephalitis virus have low transduction efficiency compared to HIV-1 vectors, due to cellular blocks during reverse transcription and integration, with the underlying mechanisms not well defined.
Innovation Solution
A plasmid-based lentiviral vector system comprising multiple plasmids, including those encoding SRLV sequences for encapsidation, rev-responsive elements, and woodchuck hepatitis virus post-transcriptional regulatory elements, which improves the transduction efficiency of lentiviral vector particles by enhancing packaging and expression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If lentiviral vectors are derived from small ruminant lentiviruses (SRLV), then safety features are improved (integration-defective and self-inactivating properties), but transduction efficiency deteriorates (more than 100-fold lower than HIV-1 vectors)
Solution Approach 1:
The patent optimizes specific parameters of the SRLV vector system including the encapsidation element sequence, rev-responsive element structure, and post-transcriptional regulatory elements to enhance transduction efficiency while preserving safety features. This involves modifying nucleic acid sequences and their arrangements to overcome cellular blocks during reverse transcription and integration.
Solution Approach 2:
The patent introduces woodchuck hepatitis virus post-transcriptional regulatory elements as intermediary components to facilitate gene expression in the SRLV vector system. These intermediary elements help overcome the low transduction efficiency by enhancing mRNA stability and translation without compromising the safety features of the SRLV-based system.
2Productivity
If multiple plasmids are used in the lentiviral vector system, then transduction efficiency is improved, but device complexity increases
Solution Approach 1:
The patent divides the lentiviral vector system into multiple functional plasmids, each carrying specific genetic elements (encapsidation elements, rev-responsive elements, post-transcriptional regulatory elements). This segmentation allows for modular optimization of transduction efficiency while maintaining clear functional separation and reducing overall system complexity through organized modularity.
Data Source
AI summary
The disclosure provides a plasmid and a lentiviral vector system which may be used to generate lentiviral vector particles for use in transduction. The disclosed vector system and/or plasmid improves the transduction efficiency of the generated lentiviral vector particles and may be exploited to provide compositions for raising immune responses in animals and as vaccines.